Endometrial polypoid adenomyoma outcomes and fertility-sparing treatments efficacy for atypical type: A systematic review and network meta-analysis

Table 3 Rankings of interventions based on their ability to suppress endometrial cancer as indicated by surface under the cumulative ranking curve analysis

Treatment	SUCRA (%)	PrBest (%)	Mean rank
TCRP	47.1	15.8	7.7
TCRP + HDP	73.1	11.9	4.2
TCRP + COC	46.8	8	7.4
TCRP + LNG-IUS	47.5	10.9	7.3
TCRP + PT	55.6	8	6.3
TCRP + GnRH-a	38.4	8.7	8.4
TCRE	51	6.2	6.9
TCRE + PT	53.6	5.6	6.6
PWH + HDP	45.9	4.6	7.5
PWH + HDP + MT	57.8	5.9	6.1
PWH	54	10.2	6.5
LNG-IUS	39.8	3.6	8.2
PT	46.9	0.6	7.4

SUCRA: Surface under the cumulative ranking curve; PrBest: Probability of being the best; TCRP: Transcervical resection of polyps; LNG-IUS: Levonorgestrel-releasing intrauterine system; COC: Combined oral contraceptive; PT: Progesterone therapy; TCRE: Transcervical resection of endometrium; HDP: High-dose progestin; MT: Hormone maintenance therapy; PWH: Polyp resection without hysteroscopy; GnRH-a: Gonadotrophin-releasing hormone agonist.